Sonnet announces passing of CEO Pankaj Mohan

• Immunotherapeutic drugs developer Sonnet BioTherapeutics Holdings (NASDAQ:SONN) announced on Tuesday the passing of founder and CEO Pankaj Mohan.
• Board Member Raghu Rao has been appointed interim CEO.
• Chief Business Officer Stephen McAndrew has been promoted to the post of President and Chief Business Officer

More on Sonnet BioTherapeutics

• Seeking Alpha’s Quant Rating on Sonnet BioTherapeutics
• Historical earnings data for Sonnet BioTherapeutics
• Financial information for Sonnet BioTherapeutics